Compare PRAX & OLLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRAX | OLLI |
|---|---|---|
| Founded | 2015 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 7.6B |
| IPO Year | 2020 | 2015 |
| Metric | PRAX | OLLI |
|---|---|---|
| Price | $305.30 | $103.66 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 13 |
| Target Price | ★ $572.13 | $140.38 |
| AVG Volume (30 Days) | 306.4K | ★ 1.1M |
| Earning Date | 05-12-2026 | 06-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 10.62 |
| EPS | N/A | ★ 2.51 |
| Revenue | N/A | ★ $2,271,705,000.00 |
| Revenue This Year | N/A | $15.58 |
| Revenue Next Year | $6,395.88 | $11.23 |
| P/E Ratio | ★ N/A | $41.61 |
| Revenue Growth | N/A | ★ 8.04 |
| 52 Week Low | $26.70 | $98.19 |
| 52 Week High | $354.87 | $141.74 |
| Indicator | PRAX | OLLI |
|---|---|---|
| Relative Strength Index (RSI) | 43.93 | 42.67 |
| Support Level | $290.36 | $98.19 |
| Resistance Level | $322.32 | $120.75 |
| Average True Range (ATR) | 16.80 | 4.04 |
| MACD | -3.79 | 0.03 |
| Stochastic Oscillator | 22.83 | 41.64 |
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.
Ollie's Bargain Outlet Holdings Inc is a retailer of closeout merchandise and excess inventory. The company sells name brand household related items that consumers use in their everyday lives at prices that are heavily discounted below traditional retailers. It offers customers a broad selection of brand name products, including housewares, bed and bath, food, floor coverings, health and beauty aids, books and stationery, toys, and electronics. It operates stores across the Eastern half of the United States. Its differentiated go-to-market plan is characterized by a fun and engaging treasure hunt shopping experience, compelling customer value proposition, and witty, humorous in-store signage and advertising campaigns.